Felty's and pseudo-Felty's syndromes.
Felty's syndrome, consisting of rheumatoid arthritis, leukopenia, and splenomegaly, has been recognized as a distinct clinical entity for more than 60 years. Clinical and laboratory manifestations of the condition are reviewed. The major sources of morbidity and mortality remain recurrent local and systemic infections. Immunogenetic analysis shows a strong association with HLA-DR4, in addition to DQ beta 3b and C4B null allele. Potential mechanisms of neutropenia are contrasted, including impaired granulopoiesis and neutrophil-immune complex interactions. Lithium carbonate and splenectomy may have a role in the treatment of fulminant disease. Maintenance therapy should be directed at control of the underlying inflammatory arthropathy. A syndrome of proliferation of large granular lymphocytes and neutropenia, associated with rheumatoid arthritis in 23% to 39% of cases, has been described recently. Cases of "pseudo-Felty's" syndrome are often confused with traditional Felty's syndrome, which has twice the prevalence. The clinical and laboratory distinctions between these two conditions are elaborated.
Rosenstein
E D
ED
Department of Medicine, UMDNJ-New Jersey Medical School, Newark.
Kramer
N
N
D015703:Antigens, CD / Q000032:analysis; D005258:Felty Syndrome / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D007125:Immunogenetics; D007239:Infections / Q000209:etiology; D007871:Leg Ulcer / Q000209:etiology; D008107:Liver Diseases / Q000209:etiology
D015703:Antigens, CD; D006680:HLA Antigens